Search

The design of a pharmaceutical cocrystal is based on the identification of specific hydrogen-bond donor and acceptor groups in active pharmaceutical ingredients (APIs) in order to choose a `complementary interacting' molecule that can act as an efficient coformer. 5-Fluorouracil (5FU) is a pyrimidine derivative with two N-H donors and C=O acceptors and shows a diversity of hydrogen-bonding motifs. Two 1:1 cocrystals of 5-fluorouracil (5FU), namely 5-fluorouracil-4-methylbenzoic acid (5FU-MBA), C4H3FN2O2·C8H8O2, (I), and 5-fluorouracil-3-nitrobenzoic acid (5FU-NBA), C4H3FN2O2·C7H5NO4, (II), have been prepared and characterized by single-crystal X-ray diffraction. In (I), the MBA molecules form carboxylic acid dimers [ R22(8) homosynthon]. Similarly, the 5FU molecules form two types of base pair via a pair of N-H...O hydrogen bonds [ R22(8) homosynthon]. In (II), 5FU interacts with the carboxylic acid group of NBA via N-H...O and O-H...O hydrogen bonds, generating an R22(8) ring motif (heterosynthon). Furthermore, the 5FU molecules form base pairs [ R22(8) homosynthon] via N-H...O hydrogen bonds. Both of the crystal structures are stabilized by C-H...F interactions. [ABSTRACT FROM AUTHOR]

Abstract: In the present study 1,2-bis(4-pyridyl)ethane (BPA) crystallizes with 2-chlorobenzoic acid (2CBA), 4-methylbenzoic acid (4MBA), phthalic acid (PA), succinic acid (SA) and adipic acid (AA) to yield co-crystals BPA.2CBA (1), BPA.4MBA (2), BPA.PA (3), BPA.SA (4) and BPA.AA (5) respectively. All the five co-crystals are constituted by the utilization of the (7) synthon, created by the combination of hard N-H⋯O and complementary soft C–H⋯O hydrogen bonds. 1 and 2 illustrate the formation of three component aggregate as in both cases BPA interacts with carboxylic acids to form supramolecular ladder-type assembies. Molecular recognition in co-crystals 3–5 results in the formation of extended infinite tapes and differ further as a consequence of the soft C–H⋯O bonds and stacking interactions. Structure 3 shows the formation of zig-zag tapes while 4 and 5 form linear infinite tapes. Structure 4 shows isostructural behaviour with an analogous structure previously reported (Bowes et al. (2003) ).The isostructurality is because of the structural resemblance between both the entities in the co-crystals – fumaric acid/succinic acid and 1,2-bis(4-pyridyl)ethane/1,2-bis(4-pyridyl)ethene. Compound 5 shows good degree of resemblance with another reported analogous structure-1,2-bis(4-pyridyl)ethene adipic acid. (Zhang et al. (2003) ). Structure 5 and the reported structure form similar supramolecular sheets through intertape interactions differing from each other only in the alignment of neighboring tapes. The linear tapes in both the cases are linked laterally through different C–H⋯O interactions and ventrally through different stacking interactions. This work illustrates the construction of different supramolecular architectures and the role of weak C–H⋯O hydrogen bonds and stacking interactions in the higher level of supramolecular organization. [Copyright &y& Elsevier]

In the title compound, C6H9N3·C7H6O3, the 2-amino-4,6-dimethyl­pyrimidine and 4-hydroxy­benzoic acid mol­ecules link together via N—H⋯O and O—H⋯N hydrogen bonds to form an eight-membered R22(8) ring. Further hydrogen bonds and C—H⋯O inter­actions result in the formation of a three-dimensional network. [ABSTRACT FROM AUTHOR]

In the title cocrystal, C6H9N3O2·C7H7NO2, the 2-amino-4,6-dimethoxy­pyrimidine mol­ecule inter­acts with the carboxyl group of the 4-amino­benzoic acid mol­ecule through N—H⋯O and O—H⋯N hydrogen bonds, forming a cyclic hydrogen-bonded motif [ R22(8)]. This motif further self-organizes through N—H⋯O hydrogen bonds to generate an array of six hydrogen bonds with the rings having the graph-set notation R23(6), R22(8), R42(8), R22(8) and R23(6). The 4-amino­benzoic acid mol­ecules self-assemble via N—H⋯O hydrogen bonds to form a supra­molecular chain along the c axis. [ABSTRACT FROM AUTHOR]